![Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]](https://i.ytimg.com/vi/ffcHWDpKZqQ/maxresdefault.jpg)
Dr. Ai on Potential With Mogamulizumab in CTCL
3 Visningar
• 08/09/23
0
0
Bädda in
administrator
Prenumeranter
Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna